This open access book is the outcome of a Global Forum on Innovation, Intellectual Property and Access to Medicines held in December 2019 at the Max Plank Instititute in Munich, organised by the South Centre and the Max Plank Institute. The academics and experts from international organisations participating have contributed chapters to this book. The book is for policy makers (in Ministries of Health, Ministries of Trade, Ministries of Foreign Affairs, patent offices), but also relevant for academics (law, trade, public health), on the flexibilities available in the Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS) of the World Trade Organization to promote access to medicines.
Les mer
Interpreting the flexibilities under the TRIPS agreement.- Intellectual Property Exhaustion and Parallel Imports of Pharmaceuticals: A Comparative and Critical Review.- Compulsory license and government use.- Access to genome editing technologies.- Bolar exception.- Patent oppositions in India.- Protection of clinical test data.- Courts and Pharmaceutical Patents.- Robust Patent Examination or Deep Harmonization? Cooperation and Work Sharing between Patent Offices .- IPRs, Competition Law and excessive pricing of medicines.- The impact of TRIPS plus rules.- Patent Linkages and its Impact on Access to Medicines.
Les mer
This open access book is the outcome of a Global Forum on Innovation, Intellectual Property and Access to Medicines held in December 2019 at the Max Plank Instititute in Munich, organised by the South Centre and the Max Plank Institute. The academics and experts from international organisations participating have contributed chapters to this book. The book is for policy makers (in Ministries of Health, Ministries of Trade, Ministries of Foreign Affairs, patent offices), but also relevant for academics (law, trade, public health), on the flexibilities available in the Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS) of the World Trade Organization to promote access to medicines.
Les mer
Highly specialised book Inter-disciplinary approach which draws wide interest Topic subject in the context of the Covid-19 pandemic This book is open access, which means that you have free and unlimited access
Les mer
Open Access This book is licensed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made. The images or other third party material in this book are included in the book's Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the book's Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
Les mer

Produktdetaljer

ISBN
9783030831134
Publisert
2021-10-28
Utgiver
Vendor
Springer Nature Switzerland AG
Høyde
235 mm
Bredde
155 mm
Aldersnivå
Research, P, 06
Språk
Product language
Engelsk
Format
Product format
Innbundet

Biographical note

Prof. Dr. Carlos María Correa is executive director of the South Centre, Geneva. He is a renowned international authority on intellectual property and technology issues.

Professor Correa has worked with the Argentine government and has been the director of the Center for Interdisciplinary Studies on Industrial Property and Economics (CEIDIE) in the Law Faculty at the University of Buenos Aires.  He was a member of the UK Commission on Intellectual Property Rights, the Commission on Intellectual Property Rights, Innovation and Public Health established by the World Health Assembly, and of the FAO Panel of Eminent Experts on Ethics in Food and Agriculture.

Professor Correa has been a visiting professor in postgraduate courses of several universities and consultant to various regional and international organisations. He has advised several governments on intellectual property, innovation policy and public health. He is the author of several books and numerous articles.

Professor Correa is both a lawyer and economist from the University of Buenos Aires and holds a PhD in Law from the University of Buenos Aires.

 

Prof. Dr. Dr. h.c. Reto M. Hilty is director at the Max Planck Institute for Competition and Innovation Munich and full professor ad personam at the University of Zurich.